Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.

Cherny, N I; Sullivan, R; Dafni, U; Kerst, J M; Sobrero, A; Zielinski, C; de Vries, E G E; Piccart, M J

Cherny, N I; Sullivan, R; Dafni, U; Kerst, J M; Sobrero, A; Zielinski, C; de Vries, E G E; Piccart, M J.

Afiliación

Cherny NI; Department of Medical Oncology, Cancer Pain and Palliative Medicine Service, Shaare Zedek Medical Center, Jerusalem, Israel chernyn@netvision.net.il.
Sullivan R; Kings Health Partners Integrated Cancer Centre, King's College London, Institute of Cancer Policy, London, UK.
Dafni U; Division of Public Health, Department of Nursing, Laboratory of Biostatistics, University of Athens, Athens, Greece.
Kerst JM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Sobrero A; Department of Medical Oncology, Ospedale San Martino, Genova, Italy.
Zielinski C; Division of Oncology, Medical University Vienna, Vienna, Austria.
de Vries EG; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Piccart MJ; Department of Medicine, Université Libre de Bruxelles, Jules Bordet Institute, Brussels, Belgium.

Ann Oncol ; 27(1): 203-5, 2016 Jan.

Article en En | MEDLINE | ID: mdl-26519490

Asunto(s)

Neoplasias/terapia; Evaluación de Resultado en la Atención de Salud/métodos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Evaluación de Resultado en la Atención de Salud / Neoplasias Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google